Quantbot Technologies LP acquired a new stake in National Health Investors, Inc. (NYSE:NHI – Free Report) in the second quarter, Holdings Channel reports. The firm acquired 11,322 shares of the real estate investment trust’s stock, valued at approximately $863,000.
A number of other hedge funds also recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new stake in National Health Investors during the 2nd quarter worth approximately $665,997,000. State Street Corp boosted its holdings in National Health Investors by 5.0% in the second quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after purchasing an additional 95,812 shares during the period. Principal Financial Group Inc. grew its stake in National Health Investors by 2.0% during the 1st quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after purchasing an additional 32,902 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in National Health Investors during the 2nd quarter worth $122,509,000. Finally, Geode Capital Management LLC increased its holdings in National Health Investors by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 1,262,657 shares of the real estate investment trust’s stock worth $96,443,000 after purchasing an additional 18,198 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Stock Down 0.1%
Shares of NYSE NHI opened at $73.31 on Thursday. The company has a market capitalization of $3.60 billion, a price-to-earnings ratio of 21.19, a price-to-earnings-growth ratio of 3.90 and a beta of 0.51. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The business has a 50-day moving average of $75.62 and a two-hundred day moving average of $78.89. National Health Investors, Inc. has a 1 year low of $67.94 and a 1 year high of $91.38.
National Health Investors Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 5.0%. The ex-dividend date is Wednesday, September 30th. National Health Investors’s dividend payout ratio is currently 108.67%.
Insider Activity at National Health Investors
In other news, Director Robert A. Mccabe, Jr. acquired 890 shares of National Health Investors stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the stock in a transaction on Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the acquisition, the chief executive officer directly owned 133,316 shares in the company, valued at $9,177,473.44. This represents a 1.14% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the company. BMO Capital Markets reduced their price target on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Truist Financial reduced their target price on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, June 12th. Wells Fargo & Company decreased their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research note on Monday, June 1st. Finally, Weiss Ratings cut shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $83.86.
Read Our Latest Stock Report on National Health Investors
About National Health Investors
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Featured Stories
- Five stocks we like better than National Health Investors
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHI – Free Report).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
